Profile
Lisa Sinclair is Senior Vice President-Corporate Operations at Arvinas, Inc. since 2022.
Formerly, Ms. Sinclair was VP-Global R&D Portfolio & Performance at AstraZeneca, Inc., Head-Programs & Alliance Management at Springworks Therapeutics, Inc., and Head-Corporate & Commercial Strategy at Rallybio Corp.
Education includes undergraduate studies at the University of Vermont.
Lisa Sinclair active positions
| Companies | Position | Start |
|---|---|---|
| ARVINAS, INC. | Chief Operating Officer | 14/08/2022 |
Former positions of Lisa Sinclair
| Companies | Position | End |
|---|---|---|
| SPRINGWORKS THERAPEUTICS, INC. | Corporate Officer/Principal | - |
AstraZeneca, Inc.
AstraZeneca, Inc. BiotechnologyHealth Technology Manufactures vaccines | Corporate Officer/Principal | - |
| RALLYBIO CORPORATION | Corporate Officer/Principal | - |
Training of Lisa Sinclair
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
University of Vermont
University of Vermont Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AstraZeneca, Inc.
AstraZeneca, Inc. BiotechnologyHealth Technology Manufactures vaccines | Health Technology |
Arvinas, Inc.
Arvinas, Inc. BiotechnologyHealth Technology Engages in discovery, development and commercialization of therapies to degrade disease-causing proteins | Health Technology |
Springworks Therapeutics, Inc.
Springworks Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops and commercializes medicines for nervous system disorders | Health Technology |
Rallybio Corp.
Rallybio Corp. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that engages in research, development and commercialization of therapies for patients with severe & rare diseases | Health Technology |
- Stock Market
- Insiders
- Lisa Sinclair
















